These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 27330533)
1. Determining the Volume of Additive Solution and Residual Plasma in Whole Blood Filtered and Buffy Coat Processed Red Cell Concentrates. Jordan A; Acker JP Transfus Med Hemother; 2016 Mar; 43(2):133-6. PubMed ID: 27330533 [TBL] [Abstract][Full Text] [Related]
2. Buffy coat (top/bottom)- and whole-blood filtration (top/top)-produced red cell concentrates differ in size of extracellular vesicles. Bicalho B; Pereira AS; Acker JP Vox Sang; 2015 Oct; 109(3):214-20. PubMed ID: 25900231 [TBL] [Abstract][Full Text] [Related]
3. Differences in residual white blood cell subset counts in buffy coat-depleted red cell concentrates prepared with bottom and top or quadruple-bag systems. de Wildt-Eggen J; Schrijver JG; Kuiper-Kramer PA; Bins M; van Prooijen HC Vox Sang; 1999; 77(2):97-102. PubMed ID: 10516554 [TBL] [Abstract][Full Text] [Related]
4. [Blood fractionation based on the extraction of the buffy-coat layer. Analysis of our results]. Algora M; Torres P; Rodríguez MA; de la Calle C; Biurrún M; Nieto S; Ruiz M; Alonso MV Sangre (Barc); 1995 Apr; 40(2):91-6. PubMed ID: 7784953 [TBL] [Abstract][Full Text] [Related]
5. [Analysis of the quality of hemoderivatives obtained using a buffy-coat extraction system with a top-and-bottom technique (Optipress II)]. Hurtado C; Bonanad S; Soler MA; Mirabet V; Blasco I; Planelles MD; de Miguel A Sangre (Barc); 1999 Oct; 44(5):319-26. PubMed ID: 10618907 [TBL] [Abstract][Full Text] [Related]
6. Quality control of buffy coat removed red cell concentrates--a Croatian experience. Vuk T; Očić T; Patko MS; Jukić I Transfus Med; 2014 Dec; 24(6):385-91. PubMed ID: 25469715 [TBL] [Abstract][Full Text] [Related]
7. [The importance of quality of whole blood and erythrocyte concentrates for autologous transfusion. A literature survey and meta-analysis of in vivo erythrocyte recovery]. Karger R; Kretschmer V Anaesthesist; 1996 Aug; 45(8):694-707. PubMed ID: 8967582 [TBL] [Abstract][Full Text] [Related]
8. [A new separation protocol (DRBCP-F) for automated blood component donation with the MCS 3p cell separator for collection of leukocyte depleted erythrocyte concentrates and plasma]. Zeiler T; Kretschmer V Beitr Infusionsther Transfusionsmed; 1997; 34():118-22. PubMed ID: 9417335 [TBL] [Abstract][Full Text] [Related]
9. Quality analysis of blood components obtained by automated buffy-coat layer removal with a top & bottom system (Optipress (R)II). Hurtado C; Bonanad S; Soler Mf; Mirabet V; Blasco I; Planelles Mf; De Miguel A Haematologica; 2000 Apr; 85(4):390-5. PubMed ID: 10756365 [TBL] [Abstract][Full Text] [Related]
10. Influence of the red blood cell preparation method on the efficacy of a leukocyte reduction filter. Alcorta I; Pereira A; Sanz C; Terol MJ; Ordinas A Vox Sang; 1996; 71(2):78-83. PubMed ID: 8873416 [TBL] [Abstract][Full Text] [Related]
11. Prestorage leukocyte depletion with in-line filtration of whole blood in comparison with blood component leukocyte depletion. Riggert J; Simson G; Dittmann J; Köhler M Vox Sang; 1995; 69(3):201-5. PubMed ID: 8578731 [TBL] [Abstract][Full Text] [Related]
12. Extending the pre-processing holding time of whole blood beyond 48 h reduces coagulation FVIII activity and immunoglobulin G content of recovered plasma. Sheffield WP; Bhakta V; Jenkins C Transfus Apher Sci; 2018 Dec; 57(6):768-772. PubMed ID: 30266202 [TBL] [Abstract][Full Text] [Related]
13. Removal of white cells from red cells by transfusion through a new filter. Sirchia G; Wenz B; Rebulla P; Parravicini A; Carnelli V; Bertolini F Transfusion; 1990 Jan; 30(1):30-3. PubMed ID: 2296786 [TBL] [Abstract][Full Text] [Related]
14. Assessing the influence of component processing and donor characteristics on quality of red cell concentrates using quality control data. Jordan A; Chen D; Yi QL; Kanias T; Gladwin MT; Acker JP Vox Sang; 2016 Jul; 111(1):8-15. PubMed ID: 26991891 [TBL] [Abstract][Full Text] [Related]
15. Prevention of red cell storage lesion: a comparison of five different additive solutions. Lagerberg JW; Korsten H; Van Der Meer PF; De Korte D Blood Transfus; 2017 Sep; 15(5):456-462. PubMed ID: 28488968 [TBL] [Abstract][Full Text] [Related]
16. [Leukocyte filtration of stored whole blood for preparation of components]. Riggert J; Simson G; Dittmann J; Wieding JU; Köhler M Beitr Infusionsther Transfusionsmed; 1994; 32():1-5. PubMed ID: 9480063 [TBL] [Abstract][Full Text] [Related]
17. In vitro variables of buffy coat-derived platelet concentrates with residual plasma of down to 10% are stably maintained in new-generation platelet additive solutions. Gravemann U; Volgmann T; Min K; Philipp R; Lambrecht B; Müller TH; Seltsam A Transfusion; 2015 Jul; 55(7):1700-9. PubMed ID: 25677807 [TBL] [Abstract][Full Text] [Related]
18. Storage of leukocyte-poor red cell concentrates: filtration in a closed system using a sterile connection device. Pietersz RN; Reesink HW; de Korte D; Dekker WJ; van den Ende A; Loos JA Vox Sang; 1989; 57(1):29-36. PubMed ID: 2508326 [TBL] [Abstract][Full Text] [Related]
19. Cytokine generation in whole blood, leukocyte-depleted and temporarily warmed red blood cell concentrates. Weisbach V; Wanke C; Zingsem J; Zimmermann R; Eckstein R Vox Sang; 1999; 76(2):100-6. PubMed ID: 10085526 [TBL] [Abstract][Full Text] [Related]
20. Characteristics of Extracellular Vesicles in Red Blood Concentrates Change with Storage Time and Blood Manufacturing Method. Almizraq RJ; Holovati JL; Acker JP Transfus Med Hemother; 2018 May; 45(3):185-193. PubMed ID: 29928174 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]